About AnGes
About AnGes
Top Message
Values
Mission
Business Area
Business Model
Company Profile
Board of Directors
Locations
History
Group
Alliance Status
Pipeline
Pipeline
Main pipeline products
Product for HGF gene therapy
NF-κB Decoy Oligo DNA
Vaccine
Global Alliance
Global Alliance
EmendoBio, Inc.
MyBiotics Pharma Ltd.
ACRL
Investor Relations
Investor Relations
IR News
Stock Performance
Financial Reports
Intellectual Property Reports
Other Information Materials
Analyst Report
IR STREET(IR related information)
IR STREET(Email Alerts)
Corporate Brochure
Contact us
COVID-19
Contact us
Site Policy
Privacy Policy
JP
EN
Leading Global in Gene Medicine
About AnGes
News
All
Development
Product Info
IR
Information
2024.06.24
IR
Strategic Change in Product Development -Collategene (HGF gene therapy product)
2024.06.06
IR
Notice Concerning Supply Agreement for "Zokinvy"
2024.05.29
IR
Tie2 receptor agonist (AV-001), co-development product, received fast track designation from the U.S. FDA
2024.05.23
IR
Notice of Launch Date for Zokinvy (Orphan Drug) for the Treatment of Progeria
2024.05.15
IR
Notice of AnGes, Inc. to Pledge Financial Support for SLDDDRS at Stanford University School of Medicine
Learn more
Pipeline
Learn more
Global Alliance
Learn more
Contact us